Ablative therapy for atrial fibrillation is becoming more commonplace, and some minimally symptomatic or asymptomatic patients will be referred for ablative therapy. Reasons to ablate asymptomatic patients include young age and/or the presence of a tachycardia induced cardiomyopathy; in addition, some symptomatic patients may become asymptomatic after ablation. Managing these patients can be challenging. In this review, we will discuss the use of antiarrhythmic agents, telemetric monitoring and guidelines for use of anticoagulation after ablation in asymptomatic patients with atrial fibrillation.
Credits: David S. Frankel, M.D.; Edward P. Gerstenfeld, M.D.